发明名称 TOPIRAMATE SALTS AND COMPOSITIONS COMPRISING AND METHODS OF MAKING AND USING THE SAME.
摘要 <p>The invention encompasses novel salts of topiramate, and pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms thereof, as well as pharmaceutical compositions and pharmaceutical unit dosage forms containing the same. In particular, the invention encompasses pharmaceutically acceptable salts of topiramate, including without limitation topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms thereof. The invention further encompasses novel co-crystals or complexes of topiramate, as well as pharmaceutical compositions comprising them. The invention also encompasses methods of treating or preventing a variety of diseases and conditions including, but not limited to, seizures, epileptic conditions, tremors, cerebral function disorders, obesity, neuropathic pain, affective disorders, tobacco cessation, migraines, and cluster headache.</p>
申请公布号 MXPA04007968(A) 申请公布日期 2005.10.18
申请号 MX2004PA07968 申请日期 2003.02.14
申请人 JOHNSON & JOHNSON 发明人 REMENAR, JULIUS
分类号 C07D473/12;A61K9/00;A61K9/16;A61K31/19;A61K31/195;A61K31/4015;A61K31/4166;A61K31/522;A61K31/53;A61K31/55;A61K31/7028;A61K47/10;A61K47/32;A61P1/08;A61P1/14;A61P3/04;A61P9/12;A61P11/02;A61P15/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/34;A61P27/02;A61P43/00;C07H5/04;C07H5/06;C07H11/00;G01N33/15 主分类号 C07D473/12
代理机构 代理人
主权项
地址